Trials / Terminated
TerminatedNCT03433937
Prevention of Seroma Following Inguinal Lymph Node Dissection With Prophylactic Incisional Negative Pressure Wound Therapy
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Odense University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Inguinal lymph node dissection (ILND) is indicated following metastatic malignant melanoma, and is associated with a high-complication rate, of which many begin with the formation of seroma and ends in complicated wound healing, reoperation, multiple outpatient visits and re-hospitalization. Prevention of seroma may therefore lead to a reduction of many of the preceding complications and improve patient quality-of-life. The aim of this study is to evaluate the efficacy and oncological safety of prophylactic negative pressure wound therapy following ILND in melanoma patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Negative pressure wound therapy | Wound dressing |
| OTHER | Micropore tape | Wound dressing |
Timeline
- Start date
- 2018-04-01
- Primary completion
- 2020-09-01
- Completion
- 2020-09-01
- First posted
- 2018-02-15
- Last updated
- 2021-06-29
Locations
4 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT03433937. Inclusion in this directory is not an endorsement.